The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3-Phenyl-6,11-dihydro-5H-indolizino [8,7-b]indole-1,2-diyl)dimethanol ID: ALA4074087
PubChem CID: 137641225
Max Phase: Preclinical
Molecular Formula: C22H20N2O2
Molecular Weight: 344.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: OCc1c(CO)c2n(c1-c1ccccc1)CCc1c-2[nH]c2ccccc12
Standard InChI: InChI=1S/C22H20N2O2/c25-12-17-18(13-26)22-20-16(15-8-4-5-9-19(15)23-20)10-11-24(22)21(17)14-6-2-1-3-7-14/h1-9,23,25-26H,10-13H2
Standard InChI Key: ZZDBOAWCKDLQRI-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
9.4105 -9.9908 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8848 -9.3244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3988 -8.6685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6255 -8.9307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9144 -8.5287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2074 -8.9438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2156 -9.7609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9308 -10.1629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6337 -9.7478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3126 -9.7710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0155 -9.3559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8368 -8.5601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0211 -8.4842 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5352 -7.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7220 -7.9203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6980 -9.2323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3755 -7.9454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1174 -7.1721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6561 -6.5616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4569 -6.7203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7192 -7.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1764 -8.1083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2326 -10.5867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8989 -11.0610 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7636 -9.6831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4196 -9.1931 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
1 9 1 0
4 9 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 1 0
10 16 2 0
13 16 1 0
2 16 1 0
3 15 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
12 17 1 0
23 24 1 0
10 23 1 0
25 26 1 0
11 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 344.41Molecular Weight (Monoisotopic): 344.1525AlogP: 3.84#Rotatable Bonds: 3Polar Surface Area: 61.18Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 2.94CX LogD: 2.94Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.53Np Likeness Score: 0.17
References 1. Chang SM, Christian W, Wu MH, Chen TL, Lin YW, Suen CS, Pidugu HB, Detroja D, Shah A, Hwang MJ, Su TL, Lee TC.. (2017) Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities., 127 [PMID:28064078 ] [10.1016/j.ejmech.2016.12.046 ]